Decision-making in the pharmaceutical industry: analysis of entrepreneurial risk and attitude using uncertain information-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Decision-making in the pharmaceutical industry: analysis of entrepreneurial risk and attitude using uncertain information

Published:2011-09 Issue:4 Volume:41 Page:321-336
ISSN:0033-6807
Container-title:R&D Management
language:en
Short-container-title:

Author:

Cowlrick Ivor¹,Hedner Thomas²,Wolf Roland³,Olausson Michael¹,Klofsten Magnus⁴

Affiliation:

1. Transplant Institute; The Sahlgrenska Academy; Göteborg University; Göteborg; Sweden

2. Center for Innovation and Entrepreneurship; The Sahlgrenska Academy; Göteborg University; Göteborg; Sweden

3. AMS Advanced Medical Services GmbH; Munich; Germany

4. Center for Innovation and Entrepreneurship; Linköping University; Linköping; Sweden

Publisher

Wiley

Subject

Management of Technology and Innovation,Strategy and Management,General Business, Management and Accounting,Business and International Management

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1467-9310.2011.00649.x/fullpdf

Reference61 articles.

1. Estimating the cost of new drug development: is it really 802 million dollars?;Adams;Health Affairs,2006

2. Distal focussing of perception: size constancy in a representative sample of situations;Brunswik;Psychological Monographs,1944

3. Differences between entrepreneurs and managers in large organizations: biases and heuristics in strategic decision making;Busenitz;Journal of Business Venturing,1997

4. Surveying free and low-cost survey software;Carter-Pokras;Journal of the National Medical Association,2006

5. Dissociating confidence and accuracy: functional magnetic resonance imaging shows origins of the subjective memory experience;Chua;Journal of Cognitive Neuroscience,2004

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Making good decisions in early drug discovery;Drug Discovery Today;2024-06

2. Research landscape analysis for quality in Pharma 4.0 era;Technology in Society;2024-03

3. The limits to upgrading and value capture in R&D global value chains: Indian and Chinese contract R&D firms in the integrated circuit design and pharmaceutical global value chains;Competition & Change;2023-09-14

4. What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study;Drug Safety;2023-02-15

5. INVESTING IN INNOVATION: THE RELATIONSHIP BETWEEN R&D SPENDING AND FINANCIAL PERFORMANCE IN THE EUROPEAN PHARMACEUTICAL INDUSTRY;J E EUR CENT ASIAN R;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3